rfxcel, the global leader in supply chain track and trace solutions and the pharma industry’s thought leader in the Verification Router Service (VRS), will exhibit at the Healthcare Distribution Alliance’s (HDA’s) 2019 Traceability Seminar October 21-23 at the Marriott Wardman Park Hotel in Washington, D.C.
The HDA is a sponsor of the seminar, an annual event that brings together healthcare supply chain leaders to learn more about implementation milestones of the Drug Supply Chain Security Act (DSCSA) — as well as innovative approaches and lessons learned — as distributors, manufacturers, and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
This year’s gathering occurs less than a month after the U.S. Food and Drug Administration (FDA) announced that it did “not intend to take action against wholesale distributors” that do not meet the DSCSA Saleable Returns Verification Requirement before November 27, 2020. This is a 1-year extension of the original deadline for wholesale distributors to verify a product identifier before further distributing a returned product.
rfxcel is leading an FDA pilot to measure VRS readiness, and is looking forward to hosting a discussion about the state of the VRS and the effects of the FDA’s deadline extension. The company will share the interim pilot report it has prepared for the FDA, which presents findings of the tests it has conducted across the VRS network of providers.
Herb Wong, rfxcel’s executive sponsor of the FDA VRS pilot, said, “We’re excited to talk about VRS and share the findings of our pilot. We also want to talk about the deadline extension, which we believe is the right decision because it will allow the industry to test more production-like scenarios. When you’re at the Traceability Seminar, visit our team at Booth 9 to talk about all the latest developments. No matter what, companies should continue with their planned VRS implementation efforts so they’ll benefit from the continued testing.”
rfxcel began its FDA-approved VRS pilot in June. It is designed to quantify the readiness of the VRS network to meet the DSCSA’s Saleable Returns Verification Requirement. The pilot builds on the HDA’s VRS efforts and will systematically verify, measure, and report on the ability of the VRS network to meet the functional requirements of VRS.
A key and unique aspect of the pilot is that rfxcel has been sharing the details of its VRS test cases with all VRS providers to ensure they have a common detailed set of test cases. rfxcel will continue to work with the providers to verify the test conditions to enable maximum readiness of the VRS network across all VRS providers.
rfxcel CEO Glenn Abood said the company was honored to participate in the HDA seminar and would be prepared to field questions. “We’re the longest-tenured track and trace solution provider in the pharma industry and the thought leader in VRS,” he said. “We’re ready to share our expertise and discuss our VRS pilot to measure and ensure the seamless interoperability between VRS providers across a broad range of use cases. Recent developments don’t change the fact that complete and consistent verification of the use cases is critical to successfully meeting the DSCSA Saleable Returns Verification Requirement. Companies should remain on course and use the extra time to ensure they’re ready for 2020.”
To learn more about rfxcel’s FDA VRS pilot, its VRS solution, and other innovative track and trace products, visit the company at Booth 9, contact Herb Wong directly, or book a meeting at rfxcel.com.
Herb Wong, VP of Marketing
rfxcel is a track and trace software provider with leading-edge solutions to help organizations track their entire supply chain, meet regulatory compliance requirements, and protect products and brand reputations. For the last 15 years, manufacturers, wholesalers, distributors, and dispensers have trusted rfxcel to provide complete compliance and traceability solutions. rfxcel’s integrated track and trace software suite delivers better business outcomes and lowers supply chain costs. The company is headquartered in the United States and has offices in the EU, Latin America, India, Russia, the Middle East, Japan, and the Asia-Pacific region.